Cargando…
Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma
Epstein-Barr virus (EBV) is associated with several B and epithelial cell cancers. EBV-encoded latent membrane protein 2A (LMP2A) contributes to cellular transformation by mimicking B cell receptor signaling. LMP2A/MYC double transgenic mice develop splenomegaly and B cell lymphoma much faster than...
Autores principales: | Cen, Osman, Kannan, Karuppiah, Huck Sappal, Jessica, Yu, Jie, Zhang, Mengkun, Arikan, Muzaffer, Ucur, Ali, Ustek, Duran, Cen, Yeter, Gordon, Leo, Longnecker, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106053/ https://www.ncbi.nlm.nih.gov/pubmed/30135222 http://dx.doi.org/10.1128/mSphereDirect.00378-18 |
Ejemplares similares
-
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)
por: Gordon, Leo I., et al.
Publicado: (2023) -
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
por: Pratz, Keith W., et al.
Publicado: (2022) -
Reactivation of Epstein–Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab Treatment
por: Febres-Aldana, Anthony J., et al.
Publicado: (2020) -
Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines
por: Kotaki, Ryutaro, et al.
Publicado: (2020) -
Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus
por: Möhl, Britta S., et al.
Publicado: (2016)